Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-22

Clinical Trial Update: The Effects of Aldara as an Adjunct to Laser Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Aldara (imiquimod) as an adjunct to laser treatment for port-wine stains was terminated, and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aldara (imiquimod)

Snippet

Sponsor: Henry Vasconez | Conditions: Port Wine Stains | Phase 2 | Status: TERMINATED | Results posted: 2018-03-22